Atossa Therapeutics
ATOS
#9179
Rank
C$0.15 B
Marketcap
C$1.17
Share price
5.11%
Change (1 day)
-34.35%
Change (1 year)

Atossa Therapeutics (ATOS) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : C$9.4 Million

According to Atossa Therapeutics's latest financial reports the company's total liabilities are C$9.4 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Atossa Therapeutics - Total liabilities on balance sheet (from 2010 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31C$7.12 M2.63%
2023-12-31C$6.94 M-8.08%
2022-12-31C$7.55 M89.65%
2021-12-31C$3.98 M-80.06%
2020-12-31C$19.98 M1046.99%
2019-12-31C$1.74 M-56.13%
2018-12-31C$3.97 M157.78%
2017-12-31C$1.54 M9.47%
2016-12-31C$1.4 M-59.44%
2015-12-31C$3.47 M31.97%
2014-12-31C$2.62 M75.51%
2013-12-31C$1.49 M-8.72%
2012-12-31C$1.64 M6.71%
2011-12-31C$1.53 M77.51%
2010-12-31C$0.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$156.59 B 1,664,694.72%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$13.16 B 139,908.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$12.16 B 129,240.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C$27.74 M 194.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
C$0.73 B 7,766.42%๐Ÿ‡บ๐Ÿ‡ธ USA